Literature DB >> 31846038

Expression of FOXP3 in Canine Gliomas: Immunohistochemical Study of Tumor-Infiltrating Regulatory Lymphocytes.

Dolors Pi Castro1,2, Roberto José-López3, Francisco Fernández Flores4, Rosa M Rabanal Prados1, Maria Teresa Mandara5, Carles Arús1,2,6,7, Martí Pumarola Batlle1,2.   

Abstract

Dogs develop gliomas with similar histopathological features to human gliomas and share with them the limited success of current therapeutic regimens such as surgery and radiation. The tumor microenvironment in gliomas is influenced by immune cell infiltrates. The present study aims to immunohistochemically characterize the tumor-infiltrating lymphocyte (TIL) population of naturally occurring canine gliomas, focusing on the expression of Forkhead box P3-positive (FOXP3+) regulatory T-cells (Tregs). Forty-three canine gliomas were evaluated immunohistochemically for the presence of CD3+, FOXP3+, and CD20+ TILs. In low-grade gliomas, CD3+ TILs were found exclusively within the tumor tissue. In high-grade gliomas, they were present in significantly higher numbers throughout the tumor and in the brain-tumor junction. CD20+ TILs were rarely found in comparison to CD3+ TILs. FOXP3+ TILs shared a similar distribution with CD3+ TILs. The accumulation of FOXP3+ Tregs within the tumor was more pronounced in astrocytic gliomas than in tumors of oligodendroglial lineage and the difference in expression was significant when comparing low-grade oligodendrogliomas and high-grade astrocytomas. Only high-grade astrocytomas presented FOXP3+ cells with tumoral morphology. In spontaneous canine gliomas, TILs display similar characteristics (density and distribution) as described for human gliomas, supporting the use of the dog as an animal model for translational immunotherapeutic studies.
© 2019 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  Canine; Glioma; Immune response; Immunohistochemistry; Regulatory T-cells; Tumor-infiltrating lymphocytes

Year:  2020        PMID: 31846038     DOI: 10.1093/jnen/nlz120

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  7 in total

1.  Intratumoral Delivery of STING Agonist Results in Clinical Responses in Canine Glioblastoma.

Authors:  C Elizabeth Boudreau; Hinda Najem; Martina Ott; Craig Horbinski; Dexing Fang; Chase M DeRay; Jonathan M Levine; Michael A Curran; Amy B Heimberger
Journal:  Clin Cancer Res       Date:  2021-08-25       Impact factor: 12.531

2.  Immune Checkpoint-Associated Locations of Diffuse Gliomas Comparing Pediatric With Adult Patients Based on Voxel-Wise Analysis.

Authors:  Li Zhang; Buyi Zhang; Zhangqi Dou; Jiawei Wu; Yasaman Iranmanesh; Biao Jiang; Chongran Sun; Jianmin Zhang
Journal:  Front Immunol       Date:  2021-03-17       Impact factor: 7.561

3.  Prognostic significance of ARL9 and its methylation in low-grade glioma.

Authors:  Yutang Tan; Suojun Zhang; Qungen Xiao; Junwen Wang; Kai Zhao; Weihua Liu; Kuan Huang; Weidong Tian; Hongquan Niu; Ting Lei; Kai Shu
Journal:  Genomics       Date:  2020-08-31       Impact factor: 5.736

4.  Immunohistochemical expression of β-catenin, Ki67, CD3 and CD18 in canine colorectal adenomas and adenocarcinomas.

Authors:  Kristin M V Herstad; Gjermund Gunnes; Runa Rørtveit; Øyvor Kolbjørnsen; Linh Tran; Ellen Skancke
Journal:  BMC Vet Res       Date:  2021-03-12       Impact factor: 2.741

5.  Evaluation of immunologic parameters in canine glioma patients treated with an oncolytic herpes virus.

Authors:  M R Chambers; J B Foote; R T Bentley; D Botta; D K Crossman; D L Della Manna; D Estevez-Ordonez; J W Koehler; C P Langford; M A Miller; J M Markert; A K Olivier; N B Omar; S R Platt; D R Rissi; A Shores; D C Sorjonen; E S Yang; A B Yanke; G Y Gillespie
Journal:  J Transl Genet Genom       Date:  2021-12-05

6.  Tumor-Associated Macrophages in Canine Oral and Cutaneous Melanomas and Melanocytomas: Phenotypic and Prognostic Assessment.

Authors:  Ilaria Porcellato; Monica Sforna; Adriana Lo Giudice; Ilaria Bossi; Alice Musi; Alessia Tognoloni; Elisabetta Chiaradia; Luca Mechelli; Chiara Brachelente
Journal:  Front Vet Sci       Date:  2022-07-22

7.  GNG12 as A Novel Molecular Marker for the Diagnosis and Treatment of Glioma.

Authors:  Runze Liu; Zhendong Liu; Yaoye Zhao; Xingbo Cheng; Binfeng Liu; Yanbiao Wang; Jialin Wang; Xiaoyu Lian; Yongjie Zhu; Yanzheng Gao
Journal:  Front Oncol       Date:  2022-07-19       Impact factor: 5.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.